Hasil Filter

14063

Total database: 17430
Struktur (SMILES)
10481 (74.5%)
Target
8038 (57.2%)
Genomik
107 (0.8%)
Referensi
14063 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (14063)

Halaman 181 / 282
small molecule | CAS: 1254885-39-6

Deskripsi belum tersedia.

Kategori:
Alkylating DrugsAntineoplastic AgentsAntineoplastic Agents, Alkylating +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Minocycline Approved DB01017
small molecule | CAS: 10118-90-8

Minocycline was first described in the literacture in 1966.[A190681] It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria.[A190723] Like other semisynthetic tetracyclines, minocycline has modificati…

Kategori:
Agents Causing Muscle ToxicityAgents that produce neuromuscular block (indirect)Alimentary Tract and Metabolism +16
Target Protein:
30S ribosomal protein S930S ribosomal protein S416S ribosomal RNA +9
Waktu ParuhThe half life of mi…
Vol. DistribusiThe volume of distr…
KlirensIntravenous minocyc…
Genetik -
Minoxidil Approved DB00350
small molecule | CAS: 38304-91-5

A potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure.

Kategori:
Antihypertensive AgentsAntihypertensive Agents Indicated for HypertensionArteriolar Smooth Muscle, Agents Acting On +13
Target Protein:
ATP-sensitive inward rectifier potassium channel 1ReninProstaglandin G/H synthase 1
Waktu Paruh4.2 hours
Vol. Distribusi-
Klirens-
Genetik -
Minzasolmin DB18961
small molecule | CAS: 1802518-92-8

Minzasolmin is under investigation in clinical trial NCT05543252 (An Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miocamycin Approved DB13287
biotech | CAS: 55881-07-7

Miocamycin is a macrolide type antimicrobial [A176170]. This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia [L5737]. It has shown to be effective against several gram-positive and gram-negative microbes and may be …

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsAntibacterials for Systemic Use +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
MIP-1095 I-123 DB12994
small molecule | CAS: 949575-25-1

123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
MIP-1095 I-131 DB14978
small molecule | CAS: 1258980-67-4

MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mipicoledine DB15075
small molecule | CAS: 942149-56-6

Mipicoledine is under investigation in clinical trial NCT01048008 (Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mipomersen Approved DB05528
biotech | CAS: 1000120-98-8

Mipomersen sodium, which was known as the investigational drug, isis-301012, is the salt form of a synthetic phosphorothioate oligonucleotide. Mipomersen sodium prevents the formation of apo B-100, resulting in a decrease in the levels of apolipoprotein B (ap…

Kategori:
Anticholesteremic AgentsAntisense Elements (Genetics)Antisense Oligonucleotides +20
Target Protein:
Apolipoprotein B-100mRNA of ApoB-100
Waktu ParuhMipomersem has a ve…
Vol. DistribusiThe volume of distr…
KlirensClearance of mipome…
Genetik -
Mipsagargin DB11813
small molecule | CAS: 1245732-48-2

Mipsagargin has been used in trials studying the treatment of Prostate Cancer, Prostatic Neoplasms, Advanced Solid Tumors, Glioblastoma Multiforme, and Hepatocellular Carcinoma, among others.

Target Protein:
Glutamate carboxypeptidase 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirabegron Approved DB08893
small molecule | CAS: 223673-61-8

Mirabegron is a sympathomimetic beta-3 adrenergic receptor agonist used to relax the smooth muscle of the bladder in the treatment of urinary frequency and incontinence. It is unique amongst overactive bladder treatment options in that, unlike other treatment…

Kategori:
Adrenergic AgentsAdrenergic AgonistsAdrenergic beta-3 Receptor Agonists +32
Target Protein:
Beta-3 adrenergic receptorBeta-1 adrenergic receptor
Waktu ParuhThe mean terminal e…
Vol. DistribusiFollowing intraveno…
KlirensTotal plasma cleara…
Genetik -
Miransertib DB14982
small molecule | CAS: 1313881-70-7

Miransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).

Kategori:
AminesPyridines
Target Protein:
RAC-gamma serine/threonine-protein kinaseRAC-alpha serine/threonine-protein kinase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miravirsen DB12851
biotech | CAS: 1072874-90-8

Miravirsen has been investigated for the treatment of Hepatitis C and Hepatitis C, Chronic.

Kategori:
Nucleic Acids, Nucleotides, and NucleosidesNucleotidesPolynucleotides
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirdametinib DB07101
small molecule | CAS: 391210-10-9

PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.

Kategori:
Acids, CarbocyclicAmidesAmines +3
Target Protein:
Dual specificity mitogen-activated protein kinase kinase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirfentanil DB09175
small molecule | CAS: 117523-47-4

Mirfentanil is a derivative of fentanyl that presents high selectivity for the mu opioid receptor. At lower doses, it antagonizes the analgesic effects of alfentanil and substitutes for naloxone in morphine-treated monkeys; however, it also reverses naloxone-…

Kategori:
Piperidines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miricorilant DB16234
small molecule | CAS: 1400902-13-7

Miricorilant is under investigation in clinical trial NCT03818256 (Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medication…

Kategori:
PyrimidinesPyrimidinones
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miridesap DB13087
small molecule | CAS: 224624-80-0

Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

Target Protein:
Serum amyloid P-component
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirikizumab Approved DB14910
biotech | CAS: 1884201-71-1

Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis. It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways contributing to the development of inflammatory diseases.[…

Kategori:
Amino Acids, Peptides, and ProteinsAnalgesicsAnti-Inflammatory Agents +16
Target Protein:
Interleukin-23 subunit alpha
Waktu ParuhThe geometric mean …
Vol. DistribusiThe geometric mean …
KlirensThe geometric mean …
Genetik -
Mirococept DB06492
biotech | CAS: 507453-82-9

Mirococept (APT070) is a complement inhibitor currently under development for treatment of rheumatoid arthritis and I/RI. It is a truncated form of the human Complement Receptor 1 (CR1) linked to a unique Prodaptin™ construct that regulates the over-productio…

Target Protein:
Complement C3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirodenafil DB11792
small molecule | CAS: 862189-95-5

Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.

Kategori:
AmidesEnzyme InhibitorsPhosphodiesterase 5 Inhibitors +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirogabalin DB11825
small molecule | CAS: 1138245-13-2

Mirogabalin has been used in trials studying the treatment of Post-herpetic Neuralgia, Pain Associated With Fibromyalgia, and Diabetic peripheral neuropathic pain.

Kategori:
AnalgesicsBridged-Ring CompoundsGabapentinoids +1
Target Protein:
Voltage-dependent calcium channel subunit alpha-2/delta-1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Miromavimab DB17803
biotech | CAS: 2247163-73-9

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirostipen DB06453
small molecule | CAS: 244130-01-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirtazapine Approved DB00370
small molecule | CAS: 85650-52-8

Mirtazapine is a tetracyclic _piperazino-azepine_ antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.[A177946] This drug was first manufactured by Organon Inc., and received FDA app…

Kategori:
Adrenergic AgentsAdrenergic alpha-2 Receptor AntagonistsAdrenergic alpha-Antagonists +38
Target Protein:
5-hydroxytryptamine receptor 2A5HT3 serotonin receptorAlpha-2A adrenergic receptor +4
Waktu Paruh20-40 hours [FDA la…
Vol. DistribusiThe volume of distr…
KlirensTotal body clearanc…
Genetik -
Mirvetuximab DB16235
biotech | CAS: 1453084-36-0

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mirvetuximab soravtansine Approved DB12489
biotech | CAS: 1453084-37-1

Mirvetuximab soravtansine-gynx (IMGN853) is an antibody-drug conjugate (ADC) formed by a monoclonal antibody (M9346A) that targets folate receptor alpha (FR?), covalently joined by a cleavable disulfide linker to the genotoxic compound DM4 (also known as sora…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +19
Target Protein:
Folate receptor alpha
Waktu ParuhAfter the first dos…
Vol. DistribusiMirvetuximab soravt…
KlirensThe total plasma cl…
Genetik -
Misoprostol Approved DB00929
small molecule | CAS: 59122-46-2

Misoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions.[L7616,L7619,A181589,A181583,A181697] The stimulation of prostaglandin receptors…

Kategori:
Abortifacient AgentsAbortifacient Agents, NonsteroidalAlimentary Tract and Metabolism +24
Target Protein:
Prostacyclin receptorProstaglandin E2 receptor EP3 subtypeProstaglandin E2 receptor EP2 subtype +2
Waktu ParuhThe half life of an…
Vol. DistribusiData regarding the …
KlirensBecause of the rapi…
Genetik -
Mitapivat Approved DB16236
small molecule | CAS: 1260075-17-9

Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells. Defects in the pyruvate kinase enzyme in various red blood cells disord…

Kategori:
Anemia, Hemolytic, Congenital, drug therapyBlood and Blood Forming OrgansCytochrome P-450 CYP1A2 Substrates +27
Target Protein:
Pyruvate kinase PKLRAromatase
Waktu ParuhIn patients with py…
Vol. DistribusiThe mean volume of …
KlirensPopulation pharmaco…
Genetik -
Mitazalimab DB15225
biotech | CAS: 2055640-86-1

Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitemcinal DB06587
small molecule | CAS: 154738-42-8

Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor.

Kategori:
Anti-Bacterial AgentsCytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 Inhibitors +5
Target Protein:
Motilin receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitiglinide DB01252
small molecule | CAS: 145375-43-5

Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.

Kategori:
Alimentary Tract and MetabolismBlood Glucose Lowering AgentsDrugs Used in Diabetes +4
Target Protein:
ATP-binding cassette sub-family C member 8ATP-sensitive inward rectifier potassium channel 10Peroxisome proliferator-activated receptor gamma
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitiperstat DB18963
small molecule | CAS: 1933460-19-5

Mitiperstat is under investigation in clinical trial NCT05492877 (An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.).

Target Protein:
Myeloperoxidase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitoglitazone DB11721
small molecule | CAS: 146062-49-9

Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

Kategori:
Sulfur CompoundsThiazoles
Target Protein:
Insulin receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitoguazone DB12967
small molecule | CAS: 459-86-9

Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

Kategori:
AmidinesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +2
Target Protein:
S-adenosylmethionine decarboxylase proenzyme
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitolactol DB12916
small molecule | CAS: 10318-26-0

Mitolactol has been used in trials studying the treatment of Brain and Central Nervous System Tumors.

Kategori:
AlcoholsAlkylating DrugsAntineoplastic Agents +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitometh DB12117
small molecule | CAS: 107465-03-2

Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung…

Kategori:
Hydrocarbons, ChlorinatedHydrocarbons, Halogenated
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitomycin Approved DB00305
small molecule | CAS: 50-07-7

Mitomycin is an antineoplastic antibiotic first isolated by Japanese microbiologists in the 1950s from cultures of _Streptomyces caespitosus_.[L12867,A193419] It is an alkylating agent that inhibits DNA synthesis (and, at higher concentrations, RNA and protei…

Kategori:
Alkylating ActivityAlkylating DrugsAntibiotics, Antineoplastic +19
Target Protein:
DNA
Waktu Paruh8-48 min
Vol. Distribusi-
Klirens-
Genetik -
Mitomycin A DB19369
small molecule | CAS: 4055-39-4

Deskripsi belum tersedia.

Kategori:
AzirinesHeterocyclic Compounds, Fused-RingIndolequinones +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitoquinone DB05063
small molecule | CAS: 444890-41-9

Mitoquinone is based on a novel technology, targeted lipophilic cations, that transport and concentrate antioxidants into the mitochondria -- organelles inside cells that provide energy for life processes -- where they accumulate up to a thousand fold. In 200…

Kategori:
BenzoquinonesCoenzymesEnzymes and Coenzymes +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mitotane Approved DB00648
small molecule | CAS: 53-19-0

Mitotane is an adrenolytic isomer of the insecticide dichlorodiphenyldichloroethane (DDD) - itself a metabolite of dichlorodiphenyltrichloroethane (DDT) - that inhibits cells of the adrenal cortex and their production of hormones. It has been in use since 195…

Kategori:
Adrenal Cytotoxic AgentsAntineoplastic AgentsAntineoplastic Agents, Hormonal +15
Target Protein:
Cytochrome P450 11B1, mitochondrialEstrogen receptorProgesterone receptor +2
Waktu ParuhThe plasma terminal…
Vol. DistribusiMitotane is extensi…
Klirens-
Genetik -
Mitoxantrone Approved DB01204
small molecule | CAS: 65271-80-9

An anthracenedione-derived antineoplastic agent.

Kategori:
AnalgesicsAnthracenesAnthracyclines and Related Substances +30
Target Protein:
DNA topoisomerase 2-betaDNADNA topoisomerase 2-alpha
Waktu Paruh75 hours
Vol. Distribusi* 1000 L/m2
Klirens* 21.3 L/hr/m2 [Eld…
Genetik -
Mitumomab DB06462
biotech | CAS: 216503-58-1

Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
MIV-711 DB15599
small molecule

Deskripsi belum tersedia.

Kategori:
Anti-Inflammatory AgentsAntineoplastic AgentsAntirheumatic Agents
Target Protein:
Cathepsin K
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mivacurium Approved DB01226
small molecule | CAS: 133814-19-4

Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.

Kategori:
Agents producing tachycardiaAnticholinergic AgentsCentral Nervous System Depressants +13
Target Protein:
Neuronal acetylcholine receptor subunit alpha-2Muscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M3 +1
Waktu ParuhThe mean eliminatio…
Vol. Distribusi-
Klirens-
Genetik -
Mivavotinib DB16849
small molecule | CAS: 1312691-33-0

Deskripsi belum tersedia.

Target Protein:
Receptor-type tyrosine-protein kinase FLT3Tyrosine-protein kinase SYK
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mivelsiran DB19003
biotech | CAS: 2572991-83-2

Mivelsiran is under investigation in clinical trial NCT06393712 (A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
ATP-dependent dethiobiotin synthetase BioD 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mizagliflozin DB19036
small molecule | CAS: 666843-10-3

Mizagliflozin is under investigation in clinical trial NCT05721729 (Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions).

Kategori:
CarbohydratesGlycosides
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mizolastine Approved DB12523
small molecule | CAS: 108612-45-9

Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).

Kategori:
Antihistamines for Systemic UseCytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP2D6 Inhibitors (strength unknown) +9
Target Protein:
Histamine H1 receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Mizoribine DB12617
small molecule | CAS: 50924-49-7

Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

Kategori:
AnalgesicsAnalgesics, Non-NarcoticAnti-Infective Agents +15
Target Protein:
Inosine-5'-monophosphate dehydrogenase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 9001–9050 dari 14063
Sebelumnya Halaman 181 / 282 Berikutnya